These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 23454404

  • 1. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK, Dmochowski RR, Reddy J, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP, Herschorn S, Albei CD, van der Meulen EA.
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [Abstract] [Full Text] [Related]

  • 3. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O, Nishizawa O, Juul KV, Nørgaard JP.
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [Abstract] [Full Text] [Related]

  • 4. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP, Zinner NR, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program.
    Yamaguchi O, Juul KV, Falahati A, Yoshimura T, Imura F, Kitamura M.
    Low Urin Tract Symptoms; 2020 Jan; 12(1):8-19. PubMed ID: 31397969
    [Abstract] [Full Text] [Related]

  • 6. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thüroff J, Riis A, Nørgaard JP.
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [Abstract] [Full Text] [Related]

  • 7. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES, Raymond K, Andruczyk E, Juul KV.
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [Abstract] [Full Text] [Related]

  • 8. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV, Klein BM, Nørgaard JP.
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [Abstract] [Full Text] [Related]

  • 9. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG, Lavery HJ, Wu DL.
    Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
    [Abstract] [Full Text] [Related]

  • 10. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.
    Weiss JP, van der Meulen EA, Juul KV.
    Eur Urol Focus; 2020 Sep 15; 6(5):1006-1012. PubMed ID: 30470646
    [Abstract] [Full Text] [Related]

  • 11. Desmopressin for treating nocturia in men.
    Han J, Jung JH, Bakker CJ, Ebell MH, Dahm P.
    Cochrane Database Syst Rev; 2017 Oct 21; 10(10):CD012059. PubMed ID: 29055129
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
    Kim JC, Cho KJ, Lee JG, Seo JT, Kim DY, Oh SJ, Lee KS, Choo MS, Lee JZ.
    J Urol; 2017 Feb 21; 197(2):459-464. PubMed ID: 27622611
    [Abstract] [Full Text] [Related]

  • 13. Re: efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study: P. K. Sand, R. R. Dmochowski, J. Reddy and E. A. van der Meulen J Urol 2013; 190: 958–964.
    Petros PP.
    J Urol; 2014 Mar 21; 191(3):875-6. PubMed ID: 24355134
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
    Chen SL, Huang YH, Hung TW, Ou YC.
    Int J Clin Pract; 2016 May 21; 70(5):372-9. PubMed ID: 27039892
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of desmopressin in women with nocturia: a systematic review and meta-analysis of randomized controlled trials.
    Cai X, Tian Y, Nie M, Wang K.
    Int Urol Nephrol; 2019 Nov 21; 51(11):1913-1923. PubMed ID: 31352583
    [Abstract] [Full Text] [Related]

  • 16. Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome.
    Hashim H, Malmberg L, Graugaard-Jensen C, Abrams P.
    Neurourol Urodyn; 2009 Nov 21; 28(1):40-6. PubMed ID: 18726947
    [Abstract] [Full Text] [Related]

  • 17. Gender difference in antidiuretic response to desmopressin.
    Juul KV, Klein BM, Sandström R, Erichsen L, Nørgaard JP.
    Am J Physiol Renal Physiol; 2011 May 21; 300(5):F1116-22. PubMed ID: 21367921
    [Abstract] [Full Text] [Related]

  • 18. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV, Malmberg A, van der Meulen E, Walle JV, Nørgaard JP.
    BJU Int; 2017 May 21; 119(5):776-784. PubMed ID: 27862898
    [Abstract] [Full Text] [Related]

  • 19. Desmopressin and nocturnal voiding dysfunction: Clinical evidence and safety profile in the treatment of nocturia.
    Chung E.
    Expert Opin Pharmacother; 2018 Feb 21; 19(3):291-298. PubMed ID: 29376448
    [Abstract] [Full Text] [Related]

  • 20. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ, Bae JH, Kim SW, Chung BH, Kim JH, Kim CS, Lee HM, Lee KS, Yoo TK, Kim SI, Byun SS, Lee JY.
    J Urol; 2013 Jul 21; 190(1):180-6. PubMed ID: 23357213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.